BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 65775)

  • 1. Hapten-specific response to a new arsonic acid conjugate, arsanil isothiocyanate.
    Bhan I; Leskowitz S
    Proc Soc Exp Biol Med; 1977 Feb; 154(2):278-84. PubMed ID: 65775
    [No Abstract]   [Full Text] [Related]  

  • 2. The separate roles of hapten and of carrier in the conformation of T cell-reactive determinants on ABA-protein conjugates.
    Ray A; Ben-Sasson S
    J Immunol; 1979 May; 122(5):1960-6. PubMed ID: 87448
    [No Abstract]   [Full Text] [Related]  

  • 3. Guinea pig T-cell in vitro proliferative responses to tyrosine-azobenzenearsonate-pulsed and azobenzenearsonate-coupled macrophages have different specificities.
    Bhan I; Leskowitz S
    Cell Immunol; 1982 Dec; 74(2):209-19. PubMed ID: 6187474
    [No Abstract]   [Full Text] [Related]  

  • 4. ABA-T determinant regulation of delayed hypersensitivity.
    Bullock WW
    Immunol Rev; 1978; 39():3-35. PubMed ID: 75168
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunochemical study of antigenic specificity in delayed hypersensitivity. II. Delayed hypersensitivity to polytyrosine-azobenzenearsonate and its suppression by haptens.
    LESKOWITZ S
    J Exp Med; 1963 Jun; 117(6):909-23. PubMed ID: 13929877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ability of hapten-conjugated cells to induce cell-mediated cytotoxicity is affected by the mode of hapten linkage.
    Nahas F; Leskowitz S
    Cell Immunol; 1980 Aug; 54(1):241-7. PubMed ID: 6967774
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigen structural requirements for activation of a T-cell-mediated anti-benzenearsonate immune response.
    Ray A; Ben-Sasson S
    Mol Immunol; 1980 Aug; 17(8):1011-8. PubMed ID: 6160387
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigenic competition in the development of delayed hypersensitivity to the azobenzenearsonate group.
    Schwartz H; Leskowitz S
    Immunochemistry; 1969 May; 6(3):503-6. PubMed ID: 4182366
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of regulation of cell-mediated immunity. II. Induction and suppression of delayed-type hypersensitivity to azobenzenearsonate-coupled syngeneic cells.
    Bach BA; Sherman L; Benacerraf B; Greene MI
    J Immunol; 1978 Oct; 121(4):1460-8. PubMed ID: 81235
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation specificity of arsonate-reactive T cell clones. Structural requirements for hapten recognition and comparison with monoclonal antibodies.
    Rao A; Faas SJ; Cantor H
    J Exp Med; 1984 Feb; 159(2):479-94. PubMed ID: 6198431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative effects in antibody formation produced by hapten-specific delayed sensitivity.
    Hanna N; Leskowitz S
    J Immunol; 1973 Aug; 111(2):410-5. PubMed ID: 4123977
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed-type hypersensitivity as revealed on the footpads of mice to azobenzenearsonate-acetyl bovine serum albumin.
    Ohuchi K; Yoshino S; Kurihara A; Yoshimura H; Ishiguro M; Kiso S; Tsurufuji S
    Int Arch Allergy Appl Immunol; 1981; 66(4):391-403. PubMed ID: 7298223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hapten-specific T cell response to azobenzenearsonate-N-acetyl-L-tyrosine in the Lewis rat. I. Induction and suppression of delayed-type hypersensitivity and in vitro proliferative responses.
    Lawn CY; Leskowitz S
    J Immunol; 1980 Dec; 125(6):2416-23. PubMed ID: 6448896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of immune responsiveness and unresponsiveness to the p-azobenzenearsonate (ABA) hapten.
    Monroe JG; Lowy A; Granstein RD; Greene MI
    Immunol Rev; 1984 Aug; 80():103-31. PubMed ID: 6237976
    [No Abstract]   [Full Text] [Related]  

  • 15. DELAYED HYPERSENSITIVITY TO A CONJUGATE OF POLYTYROSINE AND ITS INHIBITION BY HAPTENS.
    LESKOWITZ S
    Nature; 1963 Jul; 199():291-2. PubMed ID: 14076698
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of delayed hypersensitivity to the hapten by induction of tolerance to the carrier.
    Neveu PJ
    Int Arch Allergy Appl Immunol; 1978; 57(2):126-9. PubMed ID: 417034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation and inhibition of macrophages prior to immunization with a hapten-carrier conjugate.
    Neveu PJ
    Immunology; 1977 Aug; 33(2):269-73. PubMed ID: 75840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen recognition and the immune response: the capacity of L-tyrosine-azobenzenearsonate to serve as a carrier for a macromolecular hapten.
    Alkan SS; Nitecki DE; Goodman JW
    J Immunol; 1971 Aug; 107(2):353-8. PubMed ID: 4254973
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of the immune response by passive antibodies. I. Anti-hapten antibodies enhanced delayed hypersensitivity to the carrier and depressed antibody synthesis to the hapten.
    Neveu PJ; Borduas AG
    Int Arch Allergy Appl Immunol; 1975; 48(5):698-705. PubMed ID: 48508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental lung disease due to azobenzenearsonate in guinea pigs].
    Brambilla C; Youdim S; Brambilla E
    Bronchopneumologie; 1979; 29(5):378-84. PubMed ID: 519518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.